Published in Women's Health Weekly, August 1st, 2002
This preclinical study evaluated an antibody known as humanized RS7 (hRS7) that targets breast, lung, prostate, and ovarian cancers, identifying a tumor-associated molecule named "epithelial glycoprotein-1."
In this study, the hRS7 antibody was labeled with iodine-131 (I-131) using the company's recently patented method that improves the length of time the I-131 stays attached to the antibody. This new labeling method...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly